Blog

UPDATE: How to Stay Up to Date With Your COVID-19 Vaccines

March 31, 2022

Authors

Pader Moua, MPH
Policy Analyst
501-526-2244
PMoua@achi.net

Arlo Kahn, MD
Medical Director
501-526-2244
KahnRonaldF@achi.net

  • Subscribe for Updates

(Original post published March 24, 2022)

On Wednesday (March 30), the Centers for Disease Control and Prevention (CDC) updated its COVID-19 vaccine recommendations, following the U.S. Food and Drug Administration’s authorization Tuesday of a second booster dose of the Pfizer and Moderna COVID-19 vaccines for people ages 50 or older and certain immunocompromised people. The CDC’s updated recommendations allow a second booster dose of the Pfizer and Moderna COVID-19 vaccines for people ages 50 or older, for people who received the Johnson & Johnson vaccine for both the primary vaccine series and the first booster, and for immunocompromised people ages 12 or older. The second booster dose for all eligible persons should be received four months after the first booster dose, or as soon as possible if more than four months have passed.

As of March 30, 2022, the primary series and booster vaccine schedules are as follows:

Primary Series Vaccine Schedule

For people who are not immunocompromised, the CDC’s recommended primary series vaccine schedule is below.

  • Pfizer
    • Children ages 5 to 11: Two doses of the Pfizer vaccine completed three weeks apart.
    • Individuals ages 12 or older: Two doses of the Pfizer vaccine completed three weeks apart. Males ages 12‒39 may consider waiting eight weeks between the first two doses.
  • Moderna
    • Individuals ages 18 or older: Two doses of the Moderna vaccine completed four weeks apart. Males ages 12-39 may consider waiting eight weeks between the first two doses.
  • Johnson & Johnson
    • Individuals ages 18 or older: One dose of Johnson & Johnson vaccine.

For people who are moderately or severely immunocompromised, the CDC’s recommended primary vaccine schedule is as follows:

  • Pfizer
    • Children ages 5 to 11: Three doses of the Pfizer vaccine. The second dose should be completed three weeks after the first dose, and the third dose should be completed four weeks after the second dose (or as soon as possible if more than four weeks have passed).
    • Individuals ages 12 or older: Three doses of the Pfizer vaccine. The second dose should be completed three weeks after the first dose, and the third dose should be completed four weeks after the second dose (or as soon as possible if more than four weeks have passed).
  • Moderna
    • Individuals ages 18 or older: Three doses of the Moderna vaccine. The second dose should be completed four weeks after the first dose, and the third dose should be completed four weeks after the second dose (or as soon as possible if more than four weeks have passed).
  • Johnson & Johnson
    • Individuals ages 18 or older: One dose of Johnson & Johnson vaccine followed by one dose of the Pfizer or Moderna vaccine. The one dose of the Pfizer or Moderna vaccine is recommended for completion four weeks after the single dose of the Johnson & Johnson vaccine (or as soon as possible if more than four weeks have passed).

The CDC recommends that all doses of the Pfizer and Moderna primary series be the same vaccine product.

Booster Dose Vaccine Schedule

For people who are not immunocompromised, the CDC’s recommended booster vaccine schedule is below.

  • Pfizer
    • Children ages 5 to 11 who received the Pfizer vaccine for the primary series: A booster is not recommended.
    • Individuals ages 12 to 49 who received the Pfizer vaccine for the primary series: One booster dose five months after the second dose of the primary series (or as soon as possible if more than five months have passed).
    • Individuals ages 50 or older who received the Pfizer vaccine for the primary series: Two booster doses. The first booster dose should be completed five months after the second dose of the primary series. The second booster dose to be completed four months after the first booster dose (or as soon as possible if more than four months have passed).
  • Moderna
    • Individuals ages 18 to 49 who received the Moderna vaccine for the primary series: One booster dose five months after the second dose of the primary series (or as soon as possible if more than five months have passed).
    • Individuals ages 50 or older who received the Moderna vaccine for the primary series: Two booster doses. The first booster dose should be completed five months after the second dose of the primary series. The second booster dose to be completed four months after the first booster dose (or as soon as possible if more than four months have passed).
  • Johnson & Johnson
    • Individuals ages 18 to 49 who received the Johnson & Johnson vaccine for the primary series: One booster dose two months after the single primary dose of the Johnson & Johnson vaccine (or as soon as possible if more than two months have passed). Moderna or Pfizer vaccines are preferred for the booster dose.
      • Individuals in this group who received the Johnson & Johnson vaccine for both the primary series dose and first booster dose may receive a second booster dose with the Pfizer or Moderna vaccines. The second booster should be completed four months after the first booster dose of the Johnson & Johnson vaccine (or as soon as possible if more than four months have passed).
    • Individuals ages 50 or older who received the Johnson & Johnson vaccine for the primary series: Two booster doses. The first booster dose should be completed two months after the single primary dose of the Johnson & Johnson vaccine. Moderna or Pfizer vaccines are preferred for the first booster dose. The second booster using the Pfizer or Moderna vaccines should be completed four months after the first booster dose (or as soon as possible if more than four months have passed).

For people who are moderately or severely immunocompromised, the CDC recommends the following booster schedule.

  • Pfizer
    • Children ages 5 to 11 who received the Pfizer vaccine for the primary series: A booster dose is not recommended.
    • Individuals ages 12 or older who received the Pfizer vaccine for the primary series: Two booster doses. The first booster dose should be completed three months after the third dose of the primary series. The second booster dose to be completed four months after the first booster dose (or as soon as possible if more than four months have passed).
  • Moderna
    • Individuals ages 18 or older who received the Moderna vaccine for the primary series: Two booster doses. The first booster dose should be completed three months after the third dose of the primary series. The second booster dose should be completed four months after the first booster dose (or as soon as possible if more than four months have passed).
  • Johnson & Johnson
    • Individuals ages 18 or older who received a single dose of the Johnson & Johnson vaccine plus one dose of the Pfizer or Moderna vaccine for the primary series: Two booster doses. The first booster dose should be completed two months after the single dose of the Pfizer or Moderna vaccine. The second booster dose should be completed four months after the first booster dose (or as soon as possible if more than two months have passed).

Any vaccine product can be used for the first booster dose for individuals ages 18 or older; however, the Pfizer and Moderna vaccines are preferred over the Johnson & Johnson vaccine. Only the Pfizer vaccine is authorized for individuals ages 12 to 17. For individuals eligible for a second booster dose, the Pfizer or Moderna vaccines should be used. 

For the most current information, visit the CDC’s website.